S1P1/S1P3 agonists (Daiichi Sankyo Co.)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameS1P1/S1P3 agonists (Daiichi Sankyo Co.)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor 3 agonistsSphingosine 1-Phosphate Receptor 1 agonists
TargetsSphingosine 1-phosphate receptor 3Sphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A